Shareholders Equity: The sum of preferred and common equity items.
Aptose Biosciences Inc. (T.APS) had Shareholders Equity of -47.57M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-10.47M |
|
-- |
|
-- |
|
-- |
|
-9.85M |
|
-- |
|
-10.47M |
|
-10.47M |
|
-10.47M |
|
-10.47M |
|
-10.47M |
|
-10.47M |
|
-9.85M |
|
-9.85M |
|
2.55M |
|
2.55M |
|
-4.10 |
|
-4.10 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
14.71M |
|
-- |
|
-- |
|
-- |
|
62.29M |
|
-47.57M |
|
-47.57M |
|
|
Shareholders Equity |
-47.57M |
2.55M |
|
| Cash Flow Statement Financials | |
-8.01M |
|
-- |
|
8.03M |
|
5.62M |
|
5.63M |
|
0.01M |
|
0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.55 |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
22.02% |
|
22.02% |
|
-71.19% |
|
22.02% |
|
-18.64 |
|
-3.14 |
|
-3.14 |
|